ARDS - Aridis Pharmaceuticals GAAP EPS of -$0.92 misses by $0.59 revenue of $0.57M misses by $1.33M April, 01 2022 07:24 AM Aridis Pharmaceuticals Inc. Aridis Pharmaceuticals press release (NASDAQ:ARDS): Q4 GAAP EPS of -$0.92 misses by $0.59. Revenue of $0.57M misses by $1.33M. For further details see: Aridis Pharmaceuticals GAAP EPS of -$0.92 misses by $0.59, revenue of $0.57M misses by $1.33M